Skip to main content
. 2024 Apr 12;46(4):3328–3341. doi: 10.3390/cimb46040208

Figure 5.

Figure 5

MTT assay to determine cell viability percentage. (A) HEK 293 normal kidney cell treatment with different doses of isoquercitrin (IQ); (B) A493 kidney cancer cell line treated with cisplatin and isoquercitrin (IQ). ** p < 0.001 indicates significant differences from control groups.